Low concentrations of ATRA (10−11–10−9 M), sufficient to activate RARγ, stimulated the proliferation of the prostate cancer cell lines LNCaP, DU145, and PC-3, and the RARγ agonist AGN205327 exerted the same effect. This evidence concerns the gene RARG and prostate carcinoma.